289 related articles for article (PubMed ID: 7634382)
21. Effects of disopyramide and verapamil on renal disposition and nephrotoxicity of cisplatin in rats.
Hanada K; Odaka K; Kudo A; Ogata H
Pharm Res; 1999 Oct; 16(10):1589-95. PubMed ID: 10554102
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of nitric oxide synthase aggravates cisplatin-induced nephrotoxicity: effect of 2-amino-4-methylpyridine.
Saad SY; Najjar TA; Daba MH; Al-Rikabi AC
Chemotherapy; 2002; 48(6):309-15. PubMed ID: 12673106
[TBL] [Abstract][Full Text] [Related]
23. [The diminishing oocyte toxicity following intraperitoneal infusion of cisplatin (CDDP) combined with subcutaneous injection of sodium thiosulfate (STS) in syngeneic young mice].
Takizawa K; Yokoo I; Shima Y; Ozaki I; Sato M; Iguchi T; Takeda Y
Nihon Sanka Fujinka Gakkai Zasshi; 1990 Nov; 42(11):1484-8. PubMed ID: 2273302
[TBL] [Abstract][Full Text] [Related]
24. [Prophylactic effect of methylprednisolone on cisplatin-induced nephrotoxicity].
Koikawa Y
Fukuoka Igaku Zasshi; 1995 Feb; 86(2):31-9. PubMed ID: 7729781
[TBL] [Abstract][Full Text] [Related]
25. Reduction of cisplatin nephrotoxicity by sodium selenite. Lack of interaction at the pharmacokinetic level of both compounds.
Vermeulen NP; Baldew GS; Los G; McVie JG; De Goeij JJ
Drug Metab Dispos; 1993; 21(1):30-6. PubMed ID: 8095223
[TBL] [Abstract][Full Text] [Related]
26. Effect of buthionine sulphoximine, glutathione and methimazole on the renal disposition of cisplatin and on cisplatin-induced nephrotoxicity in rats: pharmacokinetic-toxicodynamic analysis.
Hanada K; Mukasa Y; Nomizo Y; Ogata H
J Pharm Pharmacol; 2000 Dec; 52(12):1483-90. PubMed ID: 11197076
[TBL] [Abstract][Full Text] [Related]
27. [New treatments for urogenital toxicity of anti-neoplastic chemotherapy].
Shibuya M; Hirosawa A; Niitani H
Gan To Kagaku Ryoho; 1990 Apr; 17(4 Pt 2):950-6. PubMed ID: 2111664
[TBL] [Abstract][Full Text] [Related]
28. Toxicodynamic evaluation of a cisplatin-chondroitin sulfate complex using a perfused kidney and human proximal tubular cells.
Zhang JS; Kadowaki D; Nonoguchi H; Hirata S; Seo H; Imai T; Suenaga A; Giam Chuang VT; Otagiri M
Ren Fail; 2011; 33(6):609-14. PubMed ID: 21631182
[TBL] [Abstract][Full Text] [Related]
29. Quantification of sodium thiosulphate protection on cisplatin-induced toxicities.
Leitao DJ; Blakley BW
J Otolaryngol; 2003 Jun; 32(3):146-50. PubMed ID: 12921131
[TBL] [Abstract][Full Text] [Related]
30. Vitamin E mitigates cisplatin-induced nephrotoxicity due to reversal of oxidative/nitrosative stress, suppression of inflammation and reduction of total renal platinum accumulation.
Darwish MA; Abo-Youssef AM; Khalaf MM; Abo-Saif AA; Saleh IG; Abdelghany TM
J Biochem Mol Toxicol; 2017 Jan; 31(1):1-9. PubMed ID: 27550472
[TBL] [Abstract][Full Text] [Related]
31. [Pharmacokinetics of cisplatin and the effect of sodium thiosulfate].
Hayata S; Hitoshi T; Kiyokawa K; Esaki S; Mihashi S; Hirano M
Gan To Kagaku Ryoho; 1984 Nov; 11(11):2356-61. PubMed ID: 6541891
[TBL] [Abstract][Full Text] [Related]
32. Magnesium co-administration decreases cisplatin-induced nephrotoxicity in the multiple cisplatin administration.
Saito Y; Okamoto K; Kobayashi M; Narumi K; Furugen A; Yamada T; Iseki K
Life Sci; 2017 Nov; 189():18-22. PubMed ID: 28864226
[TBL] [Abstract][Full Text] [Related]
33. Effects of gemcitabine on cisplatin-induced nephrotoxicity in rats: schedule-dependent study.
Saad SY; Najjar TA; Noreddin AM; Al-Rikabi AC
Pharmacol Res; 2001 Feb; 43(2):193-8. PubMed ID: 11243722
[TBL] [Abstract][Full Text] [Related]
34. Reversal of cisplatin-induced carnitine deficiency and energy starvation by propionyl-L-carnitine in rat kidney tissues.
Aleisa AM; Al-Majed AA; Al-Yahya AA; Al-Rejaie SS; Bakheet SA; Al-Shabanah OA; Sayed-Ahmed MM
Clin Exp Pharmacol Physiol; 2007 Dec; 34(12):1252-9. PubMed ID: 17973863
[TBL] [Abstract][Full Text] [Related]
35. "Two-route chemotherapy" using cis-diamminedichloroplatinum(II) and its antidote, sodium thiosulfate, combined with angiotensin II is effective against peritoneally disseminated cancer in rats.
Kobayashi H; Hasuda K; Aoki K; Kuroiwa T; Taniguchi S; Baba T
Cancer Chemother Pharmacol; 1989; 24(3):141-7. PubMed ID: 2736707
[TBL] [Abstract][Full Text] [Related]
36. [Studies on an appropriate intra thoracic administration of cisplatin and sodium thiosulfate in malignant pleural effusion].
Kitajima K; Fukuoka M; Kusunoki Y; Negoro S; Takada M; Matsui K; Sakai N; Ryu S; Takifuji N; Masuda N
Gan To Kagaku Ryoho; 1988 Dec; 15(12):3253-9. PubMed ID: 3196043
[TBL] [Abstract][Full Text] [Related]
37. [Pharmacokinetic study of cisplatin and sodium thiosulfate in two-route-infusion chemotherapy].
Ikeda K
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):1026-31. PubMed ID: 3963847
[TBL] [Abstract][Full Text] [Related]
38. Synergistic protective effect of
Abdel-Wahab WM; Moussa FI; Saad NA
Drug Des Devel Ther; 2017; 11():901-908. PubMed ID: 28356716
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of two-route chemotherapy using cis-diamminedichloroplatinum(II) and its antidote, sodium thiosulfate, in combination with angiotensin II for rat liver tumor.
Hasuda K; Kobayashi H; Aoki K; Taniguchi S; Baba T
Int J Cancer; 1989 Aug; 44(2):373-7. PubMed ID: 2759742
[TBL] [Abstract][Full Text] [Related]
40. [Effect of sodium thiosulfate on cisplatin-induced ototoxicity].
Lou WH
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1990 Aug; 25(4):208-10, 255. PubMed ID: 2076324
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
